Literature DB >> 16430226

A sensitive method for determining the phosphorylation status of natriuretic peptide receptors: cGK-Ialpha does not regulate NPR-A.

Paula M Bryan1, Dmitri Smirnov, Albert Smolenski, Susanne Feil, Robert Feil, Franz Hofmann, Suzanne Lohmann, Lincoln R Potter.   

Abstract

Natriuretic peptide receptor A (NPR-A) and natriuretic peptide receptor B (NPR-B) are transmembrane guanylyl cyclases that catalyze the synthesis of cGMP in response to natriuretic peptides. Phosphorylation and dephosphorylation regulate these receptors and have been traditionally studied by (32)PO(4) labeling of transfected cells. However, this approach cannot be used to determine the phosphorylation state of receptors isolated from unlabeled sources. Here, we use Pro-Q Diamond and SYPRO Ruby dyes to quantify the phosphorylation status and protein levels, respectively, of natriuretic peptide receptors from tissues and cells. Strong Pro-Q Diamond signals for NPR-A and NPR-B were obtained when receptors were isolated from lung tissue, liver tissue and overexpressing cells. The level of NPR-A Pro-Q staining was also high in kidney but was much lower in heart tissue. In contrast, the SYPRO Ruby protein signal was weaker and more variable. In a direct comparison, Pro-Q Diamond staining was as sensitive as but more specific than the (32)PO(4) labeling method. The two approaches were highly correlated (R(2) = 0.98). We exploited these techniques to measure the effect of cGMP-dependent protein kinase Ialpha on the phosphate content and guanylyl cyclase activity of NPR-A. Neither value was significantly affected in cells overexpressing cGK-Ialpha or in tissues from mice lacking cGK-I. We conclude that cGK-I does not regulate the cyclase activity or phosphorylation state of NPR-A. Furthermore, we find that Pro-Q Diamond staining is a sensitive method for measuring the phosphate levels of natriuretic peptide receptors, but protein levels are best detected by Western blot analysis, not SYPRO Ruby staining.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430226     DOI: 10.1021/bi051253d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

2.  The linker region in receptor guanylyl cyclases is a key regulatory module: mutational analysis of guanylyl cyclase C.

Authors:  Sayanti Saha; Kabir Hassan Biswas; Chandana Kondapalli; Nishitha Isloor; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

3.  A functional kinase homology domain is essential for the activity of photoreceptor guanylate cyclase 1.

Authors:  Grzegorz Bereta; Benlian Wang; Philip D Kiser; Wolfgang Baehr; Geeng-Fu Jang; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

Review 4.  Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch.

Authors:  Jianghui Meng; Weiwei Chen; Jiafu Wang
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

5.  Catalytically Active Guanylyl Cyclase B Requires Endoplasmic Reticulum-mediated Glycosylation, and Mutations That Inhibit This Process Cause Dwarfism.

Authors:  Deborah M Dickey; Aaron B Edmund; Neil M Otto; Thomas S Chaffee; Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2016-03-15       Impact factor: 5.157

Review 6.  Guanylyl cyclase structure, function and regulation.

Authors:  Lincoln R Potter
Journal:  Cell Signal       Date:  2011-09-10       Impact factor: 4.315

7.  A Glutamate-Substituted Mutant Mimics the Phosphorylated and Active Form of Guanylyl Cyclase-A.

Authors:  Neil M Otto; William G McDowell; Deborah M Dickey; Lincoln R Potter
Journal:  Mol Pharmacol       Date:  2017-04-17       Impact factor: 4.436

Review 8.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

Authors:  Lincoln R Potter; Andrea R Yoder; Darcy R Flora; Laura K Antos; Deborah M Dickey
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Alternative splicing of the guanylyl cyclase-A receptor modulates atrial natriuretic peptide signaling.

Authors:  Michael Hartmann; Boris V Skryabin; Thomas Müller; Alexandra Gazinski; Juliane Schröter; Birgit Gassner; Viacheslav O Nikolaev; Moritz Bünemann; Michaela Kuhn
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

10.  Dephosphorylation is the mechanism of fibroblast growth factor inhibition of guanylyl cyclase-B.

Authors:  Jerid W Robinson; Jeremy R Egbert; Julia Davydova; Hannes Schmidt; Laurinda A Jaffe; Lincoln R Potter
Journal:  Cell Signal       Date:  2017-09-28       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.